Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NVAXNovavaxCHF 1.11B-17.30―HoldUnlock the CH:NVAX analyst price target with TipRanks PremiumCH:NVAXUnlock the CH:NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$9.15$1.57B-7.3266.36%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumCH:NVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.65$795.08M-5.24-35.71%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumCH:NVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$11.02$3.60B-22.96201.09%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumCH:NVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$1.85$554.32M-3.49-47.59%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumCH:NVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NVAXNovavax―――
VIRVir Biotechnology9.153.7168.20%
ORICOric Pharmaceuticals7.65-3.83-33.36%
ABCLAbCellera Biologics11.027.41205.26%
SANASana Biotechnology1.85-1.55-45.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts